800
Participants
Start Date
January 19, 2017
Primary Completion Date
November 14, 2017
Study Completion Date
November 14, 2017
IPV-Al SSI
Total of three primary injections of IPV-Al SSI, one at 2, 4 and 6 months of age
IPV SSI
Total of three primary injections of IPV SSI, one at 2, 4 and 6 months of age
Cevaxin, Panama City
Collaborators (1)
Bill and Melinda Gates Foundation
OTHER
Larix A/S
INDUSTRY
Vaxtrials S.A.
OTHER
AJ Vaccines A/S
INDUSTRY
Statens Serum Institut
OTHER